Purpose of the Procedure
- Monitoring the effectiveness of chemotherapy or radiation.
- Early detection of cancer recurrence before it appears on imaging.
- Identifying genetic mutations to guide targeted therapy selection.
Book Liquid Biopsy (ctDNA) Test | Lahalak Medical Platform
An advanced, non-invasive blood test designed to monitor cancer progression by detecting circulating tumor DNA. It provides critical insights for treatment response evaluation and early detection of recurrence with high precision.
Scientific name: Liquid Biopsy for Circulating Tumor DNA (ctDNA)
Liquid Biopsy is a specialized laboratory test analyzing tumor DNA fragments in the bloodstream. It offers a safe, non-invasive method to monitor cancer patients' health and treatment efficacy without surgical procedures.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Venous blood sample collection
- Tumor DNA sequencing analysis
- Detailed clinical report
Medical Service Information
Target Groups
- Newly diagnosed cancer patients monitoring treatment plans.
- Cancer survivors during the regular follow-up phase.
- Patients for whom traditional tissue biopsies are difficult or risky.
Benefits of Liquid Biopsy
- Non-invasive and painless compared to tissue biopsies.
- Can be repeated frequently to track patient status easily.
- Provides a comprehensive view of genetic changes in the tumor over time.
Conditions & Notices
- Previous medical reports must be provided
- Coordination with the treating oncologist is recommended
Medical services you might also like
